Keisuke Goto, Mitsuhiko Osaki, Runa Izutsu, Hiroshi Tanaka, Ryo Sasaki, Akimitsu Tanio, . . . Futoshi Okada. (2022). Establishment of an antibody specific for AMIGO2 improves immunohistochemical evaluation of liver metastases and clinical outcomes in patients with colorectal cancer. BMC.
Chicago Style (17th ed.) CitationKeisuke Goto, et al. Establishment of an Antibody Specific for AMIGO2 Improves Immunohistochemical Evaluation of Liver Metastases and Clinical Outcomes in Patients with Colorectal Cancer. BMC, 2022.
MLA (9th ed.) CitationKeisuke Goto, et al. Establishment of an Antibody Specific for AMIGO2 Improves Immunohistochemical Evaluation of Liver Metastases and Clinical Outcomes in Patients with Colorectal Cancer. BMC, 2022.
Warning: These citations may not always be 100% accurate.